BiotechTube
AdhexPharma

AdhexPharma

Lyon, France· Est.
adhexpharma.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

AdhexPharma is a specialized CDMO focused on advanced drug delivery via patches and oral films, providing end-to-end services from development to manufacturing. The company has a significant production scale, a pipeline of over 15 development projects, and a history of strategic acquisitions to bolster its capabilities. It operates as a private, revenue-generating entity, serving pharmaceutical and biotech clients globally while also offering a portfolio of licensable, market-ready products.

Drug Delivery

Technology Platform

Specialized drug delivery platforms for transdermal patches (Impregnated Matrix Patch, Transfilm®) and oral films (Mucofilm® for mucoadhesive buccal delivery, Rapidfilm® for fast-dissolving delivery).

Opportunities

The growing demand for patient-friendly, non-invasive drug delivery systems and the pharmaceutical industry's increased reliance on outsourcing present significant growth opportunities.
Expansion into complex molecule delivery (e.g., peptides via buccal films) and geographic market penetration can further drive revenue.

Risk Factors

Key risks include client concentration, potential technological disruption in drug delivery, intense competition from larger CDMOs and niche specialists, and the ever-present regulatory and compliance risks associated with pharmaceutical manufacturing.

Competitive Landscape

AdhexPharma competes within the specialized niche of patch and film CDMOs against companies like LTS Lohmann, 3M Drug Delivery Systems, and other focused firms. It also faces broader competition from large, full-service CDMOs that may offer similar dosage forms as part of a wider portfolio.

More companies in Drug Delivery & Formulation →More companies in France →